I’m Amino AI. Ask me about peptides, GLP-1 drugs, safety, testing, cost, FDA updates, or comparisons and I’ll point you to the right Medriva page.
Independent · Evidence-ledWe don't sell peptides
The clinical record on peptides, graded by evidence.
Medriva explains the science, safety, regulatory status, and open clinical questions around peptide and GLP-1 therapies, with every claim traced to its source and rated on a transparent evidence scale.
279
Reference pages
3,400+
Primary citations
6
Named reviewers
Latest evidence
What changed in the peptide record
New trials, safety updates, regulatory movement and grade changes across the library.
Reviewed by named clinicians and editors
A standing board of clinicians, pharmacists, and reviewers
The same names listed on article review panels appear here, with specialty coverage across evidence, safety, regulatory, and access topics.
RK✓
Rina Kalra, MD
Endocrinology
JR✓
Jonathan Reeves, MD
Clinical pharmacology
AN✓
Amara Nwosu, PharmD
Safety review
ML✓
Marcus Lee, JD, MPH
Regulatory
LO✓
Lena Ortiz, MD
Internal medicine
EP✓
Elena Park, PharmD
Access and cost
Start here
Use-case hubs
Plain-language overviews of what the evidence supports for each goal, with profiles, comparisons, and safety notes underneath.
Clinical guideGrade A · StrongGrade A · Strong
Weight & metabolic · Featured hubPeptides for weight loss & GLP-1 therapy
The most rigorously studied corner of the field. We map semaglutide, tirzepatide and the GLP-1 class against trial data, real-world durability, side-effect profiles, and the regulatory line between approved drugs and compounded sources.
42 pages340 citationsUpdated May 2026
Clinical guideBB
MetabolicFat loss & recomposition
What separates evidence-backed fat-loss mechanisms from marketing claims around so-called lipolytic peptides.
16 pages88 cites
Clinical guideCC
PerformanceBodybuilding & muscle
Secretagogues, IGF pathways and recovery agents, separated by outcome data and mechanistic plausibility.
21 pages54 cites
Clinical guideCC
RecoveryHealing & injury repair
BPC-157, TB-500 and tissue-repair claims where preclinical promise meets a thin human evidence base.
19 pages119 cites
Clinical guideCC
Cognition & moodFocus & cognition
Nootropic peptides like Selank and Semax: small human trials, mostly outside Western regulatory approval.
12 pages41 cites
Clinical guideCC
LongevityAnti-aging & healthspan
Epitalon, thymic peptides and the gap between lifespan biomarkers and meaningful clinical endpoints.
19 pages37 cites
Clinical guideInsufficientInsufficient
ImmuneAutoimmune & inflammation
Thymic peptides are widely marketed for immune modulation, but controlled human data remain sparse.
14 pages22 cites
The compounds
Core peptide profiles
Each profile follows the same structure: mechanism, human evidence, dosing as studied, safety signals, and regulatory status.
Profile reviewSemaglutide
Ozempic · Wegovy
Primary useWeight loss · T2D
Human trialsPhase 3 · approved
RegulatoryFDA approved
Profile reviewTirzepatide
Mounjaro · Zepbound
Primary useWeight loss · T2D
Human trialsPhase 3 · approved
RegulatoryFDA approved
Profile reviewRetatrutide
LY3437943
Primary useWeight loss pipeline
Human trialsPhase 3 · investigational
RegulatoryNot approved
Profile reviewBPC-157
Body Protection Compound
Primary useTissue repair (claimed)
Human trialsNone completed
RegulatoryNot approved
Profile reviewIpamorelin
GH secretagogue
Primary useGH elevation
Human trialsEarly-phase only
RegulatoryNot approved
Profile reviewTB-500
Thymosin beta-4 fragment
Primary useRecovery (claimed)
Human trialsNone
RegulatoryWADA prohibited
Profile reviewCJC-1295
GHRH analog
Primary useGH / IGF-1 elevation
Human trialsSmall PK studies
RegulatoryNot approved
How Medriva grades evidence
Every page carries an A-C or Insufficient grade based on study design, human relevance, replication, and risk of bias, not popularity.
Why trust this
Editorial standards before commercial context.
Clear separation
Editorial evidence reviews stay separate from clearly labeled commercial or partner context.
Clinician-reviewed
Named physicians, pharmacists, legal reviewers and editorial specialists review pages in their specialty.
Traceable to source
3,400+ primary citations indexed, with the evidence grade shown in context.
Continuously audited
Pages carry a last-reviewed stamp and are re-checked as new trials publish.
